Immix Biopharma, INC. (IMMX) SEC Filings — 2024

Filings

• Immix Biopharma Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
• Immix Biopharma Files 10-Q for Q2 2024 — 10-Q · Aug 12, 2024
• Immix Biopharma Files 8-K: Corporate Updates — 8-K · Jul 26, 2024
• Immix Biopharma Changes Certifying Accountant — 8-K · Jul 22, 2024
• Immix Biopharma Announces Corporate Changes and Shareholder Votes — 8-K · Jun 14, 2024
• Immix Biopharma Files Proxy Materials — DEFA14A · May 21, 2024
• Immix Biopharma Reports Unregistered Equity Sales — 8-K · May 20, 2024
• Immix Biopharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Immix Biopharma, Inc. Announces Annual Meeting of Stockholders on June 11, 2024 — DEF 14A · Apr 29, 2024
• Immix Biopharma Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
• AIGH Capital Management Takes 5.8% Stake in Immix Biopharma — SC 13G · Feb 7, 2024
• IMMX Files 8-K on Material Definitive Agreement; Details Undisclosed — 8-K · Feb 6, 2024
• Immix Biopharma Files 8-K on Feb 5, Confirms Nasdaq Listing — 8-K · Feb 5, 2024